ContraFect Corp

NASDAQ:CFRX 4:00:00 PM EDT

1.91

-0.11 (-5.45%)

: $1.75 -0.16 (-8.38%)

ContraFect Corp Stock, NASDAQ:CFRX

28 Wells Avenue, 3rd Floor, Yonkers, New York 10701

United States of America

Phone: +1.914.207.2300

Number of Employees: 38

http://www.contrafect.com

Description

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.